Skip to content

2013 IDEAS Boston Speaker a 50 on Fire Nominee

October 18, 2013
Jennifer Fremont-Smith

Technology Entrepreneur Jennifer Fremont-Smith

IDEAS Boston Speaker Jennifer Fremont-Smith is one of the nominees for BostInno’s 50 on Fire, a list of individuals and institutions that keep the flames of knowledge burning bright.  (The winners will be announced in December.)

Fremont-Smith is the cofounder and COO of Smarterer, a platform designed to test and score digital and technical skills. She’s also the cofounder of Krash, a network of shared living spaces, called KrashPads, where residents immerse themselves in the culture of entrepreneurship and innovation by co-housing with like-minded people for connections, mentorship, and fun.

The daylong IDEAS Boston 2013 conference is Wednesday, October 30 at the UMass Boston Campus Center.


2008 IDEAS Boston Speaker Exploring Life Throughout Galaxy Named MacArthur Fellow

September 26, 2013
Astrophysicist Sara Seager

Astrophysicist Sara Seager

The John D. and Catherine T. MacArthur Foundation, one of the country’s largest foundations, has named astrophysicist and 2008 IDEAS Boston speaker Sara Seager one of its 2013 MacArthur fellows. The MacArthur Fellows Program awards unrestricted $625,000 fellowships to individuals who have shown extraordinary originality and dedication in their creative pursuits.

Seager is spearheading advanced hardware design and space mission projects, including ExoplanetSat, a university collaboration to build low-cost “nano-satellites” to observe planetary transits.

2004 IDEAS Boston Speaker Catches Actress Jennifer Aniston’s Attention

September 19, 2013
Picture of Robert Langer

Robert Langer

Actress Jennifer Aniston has become an investor and spokesperson for one of Robert Langer‘s projects. The MIT biomedical engineer and 2004 IDEAS Boston speaker has been collaborating with other scientists and venture capitalists on a scientifically-researched line of hair care products called Living Proof.

2011 IDEAS Boston Speaker Honored for Advocacy

September 18, 2013
Picture of Jody Adams

Jody Adams

The Greater Boston Food Bank honored chef and 2011 IDEAS Boston speaker Jody Adams at its third annual Women Fighting Hunger breakfast on September 11. Adams, the owner/chef at Rialto and Trade, was honored for her support of the GBFB’s efforts.

2004, 2013 IDEAS Boston Speakers on 3D Printers

September 6, 2013
Picture of 2004 IDEAS Boston Speaker Rodney Brooks

Robot specialist Rodney Brooks

2004 IDEAS Boston Speaker Rodney Brooks says a startup should make a 3D printer which can produce tooling.

Brooks, who invented the human-like robot Baxter to automate manual tasks in factories, spoke with reporters and analysts at the South Boston headquarters of his firm Rethink Robotics. Brooks told the Boston Business Journal that a 3D printer from Somerville-based Formlabs is being used to make custom fingers for the robot.

Formlabs cofounder Maxim Lobovsky is one of the 2013 IDEAS Boston speakers. Registration opens soon for the event, which is taking place on Wednesday, October 30 at the University of Massachusetts Boston.

2009 IDEAS Boston Speaker on New Book; Book Turned Movie, Play

August 12, 2013
Picture of Lisa Genova

Author and neuroscientist Lisa Genova

Neuroscientist, author, and 2009 IDEAS Boston speaker Lisa Genova‘s new book, Love Anthony, is about about a mother dealing with the death of her autistic son. Listen to he talk about the book, and how her book Still Alice is being turned into a film and play, in this interview with NPR.

First IDEAS Boston Speaker: Antibiotics Damage DNA

July 9, 2013

Jim Collins

2004 IDEAS Boston Speaker Jim Collins, the very first speaker recruited for this conference, is featured in the Boston Globe for his work looking at how drugs can affect our cells.

Tests on mice suggest that common antibiotics cause mitochondria to spew out factors that damage DNA, proteins, and other crucial components.

“That’s not killing the cell or causing a lot of damage, but it’s causing some damage,” Collins told the Globe.

The findings were published last week in Science Translational Medicine.